Exploring Barriers for Women in HIV Clinical Research With REPRIEVE
Throughout history, women have been excluded from clinical research studies, resulting in a dearth of knowledge about the effect that drugs might have on different sexes. This gender gap is especially obvious when looking at diseases such as HIV and heart disease, which have traditionally been seen as men’s health issues.
However, we now know that HIV-positive women are three times as likely to suffer from heart disease as women without HIV. In the U.S., about a quarter of all HIV-positive people are women, and globally, women make up about half of all people living with HIV. Thanks to antiretroviral therapy, many of these women are living longer lives, but they may develop other health problems, such as heart disease, at a younger age than their peers.